Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective

Auteurs-es

  • Ralph M. Meyer Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON; Department of Community Health and Epidemiology, Queen’s University, Kingston, ON
  • Heather A. Stanton Department of Oncology, Queen’s University, Kingston, ON
  • Wendy R. Parulekar Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON
  • Fred Saad Department of Oncology, Queen’s University, Kingston, ON; Department of Surgery, Université de Montréal, Montreal, QC

DOI :

https://doi.org/10.5489/cuaj.763

Résumé

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Bibliographies de l'auteur-e

Ralph M. Meyer, Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON; Department of Community Health and Epidemiology, Queen’s University, Kingston, ON

Heather A. Stanton, Department of Oncology, Queen’s University, Kingston, ON

Wendy R. Parulekar, Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON

Fred Saad, Department of Oncology, Queen’s University, Kingston, ON; Department of Surgery, Université de Montréal, Montreal, QC

Téléchargements

Comment citer

Meyer, R. M., Stanton, H. A., Parulekar, W. R., & Saad, F. (2013). Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective. Canadian Urological Association Journal, 5(6), 379–81. https://doi.org/10.5489/cuaj.763

Numéro

Rubrique

Letters